Molecular Innovations, Inc. – Trademark Portfolio

Entity Type: 03

Molecular Innovations, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MOLECULAR INNOVATIONS. The owner is based in Denver, CO.

717 Yosemite Circle

Denver, CO 80220

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Molecular Innovations, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Molecular Innovations, Inc. have?

Molecular Innovations, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does Molecular Innovations, Inc. file in?

Molecular Innovations, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Molecular Innovations, Inc.'s most well-known trademarks?

Molecular Innovations, Inc.'s registered trademark portfolio includes well-known marks such as MOLECULAR INNOVATIONS. These are among 1 currently registered trademark in the portfolio.

What is Molecular Innovations, Inc.'s trademark registration success rate?

Molecular Innovations, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.